{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:50:47Z","timestamp":1790049047509,"version":"4.0.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1124\/jpet.116.233627","type":"journal-article","created":{"date-parts":[[2016,5,13]],"date-time":"2016-05-13T02:28:56Z","timestamp":1463106536000},"page":"71-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["The Rapidly Acting Antidepressant Ketamine and the mGlu2\/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits"],"prefix":"10.1016","volume":"358","author":[{"given":"J.M.","family":"Witkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Monn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.D.","family":"Schoepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Overshiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.N.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.M.","family":"Rorick-Kehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.116.233627_bib1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/08039488.2012.752035","article-title":"Psychostimulants in moderate to severe affective disorder: a systematic review of randomized controlled trials","volume":"67","author":"Abbasowa","year":"2013","journal-title":"Nord J Psychiatry"},{"key":"10.1124\/jpet.116.233627_bib2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev-med-053013-062946","article-title":"Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics","volume":"66","author":"Abdallah","year":"2015","journal-title":"Annu Rev Med"},{"key":"10.1124\/jpet.116.233627_bib3","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.bcp.2005.12.022","article-title":"A role for AMPA receptors in mood disorders","volume":"71","author":"Alt","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.116.233627_bib4","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1177\/0269881113494104","article-title":"Anhedonia revisited: is there a role for dopamine-targeting drugs for depression?","volume":"27","author":"Argyropoulos","year":"2013","journal-title":"J Psychopharmacol"},{"key":"10.1124\/jpet.116.233627_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"10.1124\/jpet.116.233627_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0022-3565(25)24277-X","article-title":"Evaluation of antagonists of the discriminative stimulus and response rate effects of phencyclidine","volume":"244","author":"Beardsley","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.233627_bib7","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.biopsych.2014.04.014","article-title":"Restoring mood balance in depression: ketamine reverses deficit in dopamine-dependent synaptic plasticity","volume":"76","author":"Belujon","year":"2014","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.116.233627_bib8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.116.233627_bib9","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/JCP.0000000000000335","article-title":"Assessment of the efficacy and safety of BMS-820836 in patients with treatment-resistant major depression: results from 2 randomized, double-blind studies","volume":"35","author":"Bhagwagar","year":"2015","journal-title":"J Clin Psychopharmacol"},{"key":"10.1124\/jpet.116.233627_bib10","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.euroneuro.2015.07.002","article-title":"Ketamine-like effects of a combination of olanzapine and fluoxetine on AMPA and NMDA receptor-mediated transmission in the medial prefrontal cortex of the rat","volume":"25","author":"Bj\u00f6rkholm","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/jpet.116.233627_bib11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00213-001-0986-x","article-title":"Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex","volume":"160","author":"Bymaster","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.116.233627_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnbeh.2014.00188","article-title":"Local control of striatal dopamine release","volume":"8","author":"Cachope","year":"2014","journal-title":"Front Behav Neurosci"},{"key":"10.1124\/jpet.116.233627_bib13","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nature11713","article-title":"Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons","volume":"493","author":"Chaudhury","year":"2013","journal-title":"Nature"},{"key":"10.1124\/jpet.116.233627_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0014-2999(97)01019-4","article-title":"Dizocilpine prevents the enhanced locomotor response to quinpirole induced by repeated electroconvulsive shock","volume":"330","author":"D\u2019Aquila","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.116.233627_bib15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0014-2999(00)00566-5","article-title":"The role of dopamine in the mechanism of action of antidepressant drugs","volume":"405","author":"D\u2019Aquila","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.116.233627_bib16","first-page":"223","article-title":"Effects of sustained serotonin reuptake inhibition on the firing of dopamine neurons in the rat ventral tegmental area","volume":"34","author":"Dremencov","year":"2009","journal-title":"J Psychiatry Neurosci"},{"key":"10.1124\/jpet.116.233627_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuropharm.2011.08.044","article-title":"Signaling pathways underlying the rapid antidepressant actions of ketamine","volume":"62","author":"Duman","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.116.233627_bib18","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1017\/S1461145711001702","article-title":"mTOR activation is required for the antidepressant effects of mGluR\u2082\/\u2083 blockade","volume":"15","author":"Dwyer","year":"2012","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/jpet.116.233627_bib19","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1126\/science.7197394","article-title":"Increased intracranial self-stimulation in rats after long-term administration of desipramine","volume":"214","author":"Fibiger","year":"1981","journal-title":"Science"},{"key":"10.1124\/jpet.116.233627_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0304-3940(90)90823-R","article-title":"Non-competitive N-methyl-D-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons","volume":"119","author":"French","year":"1990","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.116.233627_bib21","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/npp.2015.233","article-title":"The antidepressant effects of an mGlu2\/3 receptor antagonist and ketamine require AMPA receptor stimulation in the mPFC and subsequent activation of the 5-HT neurons in the DRN","volume":"41","author":"Fukumoto","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.116.233627_bib22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0306-4522(83)90135-5","article-title":"Intracellular and extracellular electrophysiology of nigral dopaminergic neurons--1. Identification and characterization","volume":"10","author":"Grace","year":"1983","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.116.233627_bib23","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1111\/j.1471-4159.2010.07066.x","article-title":"Rapid microelectrode measurements and the origin and regulation of extracellular glutamate in rat prefrontal cortex","volume":"115","author":"Hascup","year":"2010","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.116.233627_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbr.2006.05.035","article-title":"Role of the ventral subiculum in stress integration","volume":"174","author":"Herman","year":"2006","journal-title":"Behav Brain Res"},{"key":"10.1124\/jpet.116.233627_bib25","doi-asserted-by":"crossref","first-page":"11496","DOI":"10.1523\/JNEUROSCI.2213-07.2007","article-title":"NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons","volume":"27","author":"Homayoun","year":"2007","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.116.233627_bib26","series-title":"Biology of Depression: from Novel Insights to Therapeutic Strategies","first-page":"71","article-title":"The monoamine hypothesis of depression","author":"Iversen","year":"2005"},{"key":"10.1124\/jpet.116.233627_bib27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neuroscience.2010.12.012","article-title":"Mechanisms underlying ketamine-induced synaptic depression in rat hippocampus-medial prefrontal cortex pathway","volume":"177","author":"Kamiyama","year":"2011","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.116.233627_bib28","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.neuint.2010.07.011","article-title":"AMPA receptor mediates mGlu 2\/3 receptor antagonist-induced dopamine release in the rat nucleus accumbens shell","volume":"57","author":"Karasawa","year":"2010","journal-title":"Neurochem Int"},{"key":"10.1124\/jpet.116.233627_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0028-3908(97)00191-3","article-title":"LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors","volume":"37","author":"Kingston","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.116.233627_bib30","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.neuropharm.2003.09.001","article-title":"Brain region and dose effects of an olanzapine\/fluoxetine combination on extracellular monoamine concentrations in the rat","volume":"46","author":"Koch","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.116.233627_bib31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2011.05.035","article-title":"Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression","volume":"224","author":"Koike","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1124\/jpet.116.233627_bib32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s002130051049","article-title":"Interactive effects of subanesthetic ketamine and haloperidol in healthy humans","volume":"145","author":"Krystal","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.116.233627_bib33","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1038\/tp.2014.105","article-title":"Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression","volume":"4","author":"Lally","year":"2014","journal-title":"Transl Psychiatry"},{"key":"10.1124\/jpet.116.233627_bib34","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1177\/0269881114568041","article-title":"Neural correlates of change in major depressive disorder anhedonia following open-label ketamine","volume":"29","author":"Lally","year":"2015","journal-title":"J Psychopharmacol"},{"key":"10.1124\/jpet.116.233627_bib35","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1124\/jpet.116.233627_bib36","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1023\/A:1023648923447","article-title":"Enhancement of antidepressant potency by a potentiator of AMPA receptors","volume":"23","author":"Li","year":"2003","journal-title":"Cell Mol Neurobiol"},{"key":"10.1124\/jpet.116.233627_bib37","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s002130050449","article-title":"Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine","volume":"134","author":"Li","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.116.233627_bib38","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bbr.2014.11.016","article-title":"Dopamine D2\/D3 but not dopamine D1 receptors are involved in the rapid antidepressant-like effects of ketamine in the forced swim test","volume":"279","author":"Li","year":"2015","journal-title":"Behav Brain Res"},{"key":"10.1124\/jpet.116.233627_bib39","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.116.233627_bib40","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejphar.2008.10.051","article-title":"The MCH1 receptor antagonist SNAP 94847 induces sensitivity to dopamine D2\/D3 receptor agonists in rats and mice","volume":"602","author":"Marsteller","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.116.233627_bib41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.nurt.2008.10.039","article-title":"Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs","volume":"6","author":"Millan","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1124\/jpet.116.233627_bib42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuropharm.2015.07.028","article-title":"Two cellular hypotheses explaining the initiation of ketamine\u2019s antidepressant actions: Direct inhibition and disinhibition","volume":"100","author":"Miller","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.116.233627_bib43","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.116.233627_bib44","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/schbul\/sbs075","article-title":"Capturing the angel in \u201cangel dust\u201d: twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans","volume":"38","author":"Moghaddam","year":"2012","journal-title":"Schizophr Bull"},{"key":"10.1124\/jpet.116.233627_bib45","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neuroscience.2014.05.032","article-title":"Glutamate neurons within the midbrain dopamine regions","volume":"282C","author":"Morales","year":"2014","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.116.233627_bib46","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1037\/h0058775","article-title":"Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain","volume":"47","author":"Olds","year":"1954","journal-title":"J Comp Physiol Psychol"},{"key":"10.1124\/jpet.116.233627_bib47","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/mp.2013.144","article-title":"Serotonin 2C receptor antagonists induce fast-onset antidepressant effects","volume":"19","author":"Opal","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1124\/jpet.116.233627_bib68","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1124\/jpet.116.233627_bib48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0091-6773(76)91226-8","article-title":"Long-term deficits in stimulation-induced behaviors and self-stimulation after 6-hydroxydopamine administration in rats","volume":"16","author":"Phillips","year":"1976","journal-title":"Behav Biol"},{"key":"10.1124\/jpet.116.233627_bib49","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1124\/jpet.116.233627_bib50","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/npp.2009.104","article-title":"Neurocircuitry of mood disorders","volume":"35","author":"Price","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.116.233627_bib51","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s002130050555","article-title":"Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test","volume":"136","author":"R\u00e9n\u00e9ric","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.116.233627_bib52","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1124\/jpet.116.233627_bib53","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/npp.2014.261","article-title":"Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?","volume":"40","author":"Sanacora","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.116.233627_bib54","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/187152707780363285","article-title":"Triple reuptake inhibitors (\u201cbroad spectrum\u201d antidepressants)","volume":"6","author":"Skolnick","year":"2007","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1124\/jpet.116.233627_bib55","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0014-2999(81)90531-8","article-title":"Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine","volume":"74","author":"Spyraki","year":"1981","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.116.233627_bib56","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuroscience.2012.03.052","article-title":"Antidepressant-like effects of low ketamine dose is associated with increased hippocampal AMPA\/NMDA receptor density ratio in female Wistar-Kyoto rats","volume":"213","author":"Tizabi","year":"2012","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.116.233627_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(90)90204-J","article-title":"Functional antagonists at the NMDA receptor complex exhibit antidepressant actions","volume":"185","author":"Trullas","year":"1990","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.116.233627_bib58","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000136753","article-title":"Does REM sleep deprivation induce a supersensitivity of dopaminergic receptors in the rat brain?","volume":"16","author":"Tufik","year":"1978","journal-title":"Pharmacology"},{"key":"10.1124\/jpet.116.233627_bib59","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature11740","article-title":"Dopamine neurons modulate neural encoding and expression of depression-related behaviour","volume":"493","author":"Tye","year":"2013","journal-title":"Nature"},{"key":"10.1124\/jpet.116.233627_bib60","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bcp.2009.04.008","article-title":"Targeting glial physiology and glutamate cycling in the treatment of depression","volume":"78","author":"Valentine","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.116.233627_bib61","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1177\/0269881107077347","article-title":"Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors","volume":"21","author":"Weikop","year":"2007","journal-title":"J Psychopharmacol"},{"key":"10.1124\/jpet.116.233627_bib62","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1017\/S1461145710000489","article-title":"Effects of chronic antidepressant drug administration and electroconvulsive shock on activity of dopaminergic neurons in the ventral tegmentum","volume":"14","author":"West","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"issue":"Suppl 3","key":"10.1124\/jpet.116.233627_bib63","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/00004850-199707003-00002","article-title":"The mesolimbic dopamine system as a target for rapid antidepressant action","volume":"12","author":"Willner","year":"1997","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1124\/jpet.116.233627_bib64","unstructured":"Witkin JM, Li X, Barth V, Rash K, Catlow J, Anderson W, Rasmussen K, Bleakman D, Baker K, Dunlop J, et al. (2011) Can a Model with Predictive Validity for Clinical Efficacy in Treatment-Resistant Depression Be Derived from the Differential Behavioral Effects of Drugs across Mouse Strains? American College of Neuropsychopharmacology, Brentwood, TN."},{"key":"10.1124\/jpet.116.233627_bib65","doi-asserted-by":"crossref","unstructured":"Witkin JM, Ornstein PL, Mitch CH, Li R, Smith SC, Heinz BA, Wang XS, Xiang C, Carter JH, Anderson WH, et al. (2016) In vitro pharmacological and rat pharmacokinetic characterization of LY3020371, a potent and selective mGlu2\/3 receptor antagonist. Neuropharmacology DOI: 10.1016\/j.neuropharm.2015.12.021. [published ahead of print].","DOI":"10.1016\/j.neuropharm.2015.12.021"},{"key":"10.1124\/jpet.116.233627_bib66","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1124\/jpet.116.233627_bib67","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0893-133X(00)00119-6","article-title":"Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex","volume":"23","author":"Zhang","year":"2000","journal-title":"Neuropsychopharmacology"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524193391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524193391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.116.233627","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:46:08Z","timestamp":1739994368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524193391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0022356524193391"],"URL":"https:\/\/doi.org\/10.1124\/jpet.116.233627","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Rapidly Acting Antidepressant Ketamine and the mGlu2\/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.116.233627","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}